New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
20:25 EDTPM, PM, SAP, SAP, UNH, UNH, DHR, DHR, BAX, BAX, BHI, BHI, MAS, MASNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Morgan Stanley (MS), consensus 55c; Philip Morris (PM), consensus $1.24; SAP (SAP), consensus 76c; UnitedHealth Group (UNH), consensus $1.26; Danaher (DHR), consensus 94c; Baxter (BAX), consensus $1.22; Baker Hughes (BHI), consensus 90c.
News For MAS;PM;SAP;UNH;DHR;BAX;BHI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 21, 2015
09:19 EDTSAPSAP shares should be bought on weakness, says JMP Securities
Subscribe for More Information
09:16 EDTUNHOn The Fly: Pre-market Movers
Subscribe for More Information
08:07 EDTSAPSAP price target lowered to $75 from $87 at Argus
Subscribe for More Information
06:06 EDTUNHUnitedHealth: Employer & Individual revenues decreased to $43B in 2014
Subscribe for More Information
06:05 EDTUNHUnitedHealth: ACA negatively impacted FY earnings by $1.00 per share
Subscribe for More Information
06:02 EDTUNHUnitedHealth sees FY15 EPS $6.00-$6.25, consensus $6.17
Subscribe for More Information
06:01 EDTUNHUnitedHealth reports Q4 EPS $1.55, consensus $1.50
Subscribe for More Information
January 20, 2015
15:21 EDTUNHNotable companies reporting before tomorrow's open
Subscribe for More Information
12:57 EDTUNHUnitedHealth volatility elevated into Q4 and outlook
Subscribe for More Information
09:22 EDTBHIHalliburton sees restructuring charge in Q1
Subscribe for More Information
09:11 EDTBHI, SAPOn The Fly: Pre-market Movers
Subscribe for More Information
09:02 EDTBAXBaxter receives FDA approval for PHOXILLUM solution
Subscribe for More Information
08:30 EDTBHIBaker Hughes to cut 7K jobs in Q1 amid low oil prices
Subscribe for More Information
08:16 EDTBAXMerrimack data of Phase 3 MM-398 NAPOLI-1 study supports development programs
Merrimack Pharmaceuticals (MACK) announced that additional analyses were presented on January 16, 2015 from the Phase 3 NAPOLI-1 study of MM-398, also known as nal-IRI, in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy. Merrimack and Baxter International's (BAX) biopharmaceutical business are collaborating on the development and commercialization of MM-398 outside of the United States and Taiwan. PharmaEngine holds the rights to commercialize MM-398 in Taiwan. Additionally, Merrimack presented preclinical and clinical data from studies of its investigational agents MM-141 and MM-151 in pancreatic and colorectal cancer, respectively. An investigator-sponsored study of MM-398 in colorectal cancer was also presented. The extended analyses for the global NAPOLI-1 Phase 3 trial presented at ASCO GI support the robustness of the overall survival benefit of MM-398 in combination with 5-fluorouracil, or 5-FU, and leucovorin presented in June 2014, at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer, or ESMO GI. The primary analysis, presented at ESMO GI, demonstrated a statistically significant advantage in overall survival with an unstratified hazard ratio of 0.67, and a median of 6.1 months for the combination of MM-398 plus 5-FU and leucovorin compared to 4.2 months in the control arm.
07:39 EDTBHIBaker Hughes sees FY15 interest expense approx. $240M
Subscribe for More Information
07:15 EDTSAPSAP not interested in buying competitors Workday, Salesforce, Bloomberg reports
Subscribe for More Information
07:02 EDTBHIHalliburton reports Q4 C&P revenue $5.5B, D&E revenue $3.3B
During the fourth quarter of 2014, Halliburton (HAL) incurred $19M for costs related to the pending Baker Hughes (BHI) acquisition.
06:01 EDTBHIBaker Hughes reports Q4 adj. EPS $1.44, consensus $1.07
Subscribe for More Information
05:25 EDTSAPSAP reports preliminary Q4 non-IFRS EPS EUR 1.31 vs. EUR 1.28 last year
Subscribe for More Information
January 18, 2015
14:22 EDTBHISchlumberger boss says oil price to challenge land producers, WSJ says
Paal Kibsgaard, CEO of Schlumberger, said U.S. energy producers are not done with work force reductions and that because of high costs, producers that focus on shale fields are worse off than rivals, says the Wall Street Journal. Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A), Total (TOT), Schlumberger (SLB) and Baker Hughes (BHI). Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use